{"version":"1.0","type":"rich","width":"560px","height":"140px","title":"Prevention\u00a0of infections during\u00a0treatment with bispecific antibodies and CAR T cells in\u00a0multiple myeloma\u200b","url":"https:\/\/www.myelomasociety.org\/prevention-of-infections-during-treatment-with-bispecific-antibodies-and-car-t-cells-in-multiple-myeloma\/","author_name":"IMSound","author_url":"https:\/\/www.myelomasociety.org","thumbnail_url":"https:\/\/www.myelomasociety.org\/wp-content\/uploads\/2024\/07\/IMSound-Logo-only-v2.png","html":"<iframe width=\"560px\" height=\"140px\" src=\"https:\/\/www.myelomasociety.org\/prevention-of-infections-during-treatment-with-bispecific-antibodies-and-car-t-cells-in-multiple-myeloma\/?standalonePlayer\"><\/iframe>"}